| anaphylaxis following quadrivalent human papillomavirus vaccination. | in 2007, australia implemented the national human papillomavirus (hpv) vaccination program, which provides quadrivalent hpv vaccine free to all women aged 12-26 years. following notification of 7 presumptive cases of anaphylaxis in the state of new south wales, australia, we verified cases and compared the incidence of anaphylaxis following hpv vaccination to other vaccines in comparable settings. | 2008 | 18762618 |
| immunisation coverage, 2012. | this, the 6th annual immunisation coverage report, documents trends during 2012 for a range of standard measures derived from australian childhood immunisation register (acir) data, and national human papillomavirus (hpv) vaccination program register data. these include coverage at standard age milestones and for individual vaccines included on the national immunisation program (nip) and coverage in adolescents and adults. the proportion of australian children 'fully vaccinated' at 12, 24 and 60 ... | 2014 | 25391407 |
| immunisation coverage annual report, 2011. | this, the 5th annual immunisation coverage report, documents trends during 2011 for a range of standard measures derived from australian childhood immunisation register data, and national human papillomavirus (hpv) vaccination program register data. the proportion of children 'fully vaccinated' at 12, 24 and 60 months of age was 91.4%, 92.2% and 89.5% respectively. although pneumococcal vaccine had similar coverage at 12 months to other vaccines, coverage was lower for rotavirus at 12 months (83 ... | 2013 | 24882234 |
| four decades of anal cancer in tasmania, australia: what do the case data tell us? | anal cancer is a rare cancer analogous to cervical cancer, largely caused by exposure to oncogenic human papillomavirus. we have sought to study this disease in the epidemiologically distinct population of tasmania. | 2012 | 22697137 |